Altimmune Inc (NASDAQ:ALT)
| 1.84 Delayed Data As of 1:01pm ET |  0.00 / 0.00%Today’s Change | 1.51 Today|||52-Week Range 5.94 | -10.68% Year-to-Date |
Latest ALT News | Press Releases
No recent news for Altimmune Inc.
Today’s Trading
| Previous close | 1.84 |
| Today’s open | 1.85 |
| Day’s range | 1.84 - 1.90 |
| Volume | 34,602 |
| Average volume (3 months) | 127,278 |
| Market cap | $29.1M |
Data as of 1:01pm ET, 12/10/2019
Growth & Valuation
| Earnings growth (last year) | +87.40% |
| Earnings growth (this year) | +94.13% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -3.79% |
| P/E ratio | 1.9 |
| Price/Sales | 0.56 |
| Price/Book | 0.36 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BNGOBionano Genomics Inc | -0.05 | -4.63% |
| APVOAptevo Therapeutics ... | +0.02 | +2.71% |
| SAVACassava Sciences Inc | -0.24 | -13.41% |
| IGCIndia Globalization ... | -0.02 | -2.44% |
Data as of 1:09pm ET, 12/10/2019
Financials
| Next reporting date | March 25, 2020 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $10.3M |
| Annual profit (last year) | -$39.2M |
| Net profit margin | -379.16% |
Profile
Sector Commercial Services |
Industry Miscellaneous Commercial Services |
No executives to display |
Corporate headquarters Gaithersburg, Maryland |
Forecasts
